TSE (also known as prion diseases) are a group of progressive conditions affecting the brain and nervous systems of many animals and humans. The conditions include Creutzfeldt-Jakob disease (the human form of mad cow disease), Gerstmann-Sträussler-Scheinker syndrome, fatal familial insomnia and kuru, all forming a spectrum of overlapping signs and symptoms caused by a myriad of tiny holes in the cortex that give it the appearance of a sponge. The disease impairs brain functions leading to both mental and physical deterioration over time.
Using a synthetic prion protein made in E. coli, the researchers induced a new form of TSE. Their study findings—published in January 2010 issue of Acta Neuropathol (with open access at Springerlink.com)— indicate a slow progression of the disease after the observance of first clinical signs, which is typical of how the disease unfolds in both humans and large animals, than in smaller animals such as rodents.
One of the study’s lead researchers, Robert Rohwer, PhD, director of Molecular Neurovirology Laboratory at the VA Maryland Health Care System and an associate professor at the University of Maryland School of Medicine, says the result is an “important milestone in establishing that the native wild-type prion protein is sufficient to induce prion disease in normal wild-type hosts. The interpretation of previous transmissions with synthetic prion proteins has been confounded by the use of mutant proteins and mutant host recipients subject to spontaneous disease.”
This result, Rohwer said, does not explain the many discrepancies “that have supported skeptics of the prion hypothesis like myself, and there is enormous work yet to be done to reconcile these apparent inconsistencies. However, the new insights, tools and focus provided by these discoveries promise to greatly accelerate the pace of those efforts.” Rohwer noted that the disease being induced “was itself unique and fascinating” and may prove valuable as a window on its progression in humans, cattle and sheep.
Rohwer, together with Ilia Backakov, PhD, an associate professor at the School of Medicine and director of the Prion Insitute at the University of Maryland’s Biotechnolgical Institute, inoculated Golden Syrian hamsters with synthetic E.coli recombinant prion proteins, while at the same time inoculating other hamsters with comprehensive slightly altered controls. During this first passage, all but two of the hamsters survived to old age (18 months) without any sign of disease. The researchers investigated the brains of each hamster at 18 months old for evidence of the TSE infection, finding that one animal showed definite signs of infection and one suspicious. They homogenized the brains of both the possibly infected and apparently uninfected animals that had been inoculated with prion protein and some control group hamsters, and then inoculated the homogenates in new animals. Again the animals appeared normal for more than a year after the inoculation, but then the animals began developing symptoms of TSE disease.
“There had been infection in the first passage, but the disease progression was so slow it didn’t have time to advance to a symptomatic form within the hamster’s lifespan,” said Rohwer.
In the hamsters from the second passage, a higher concentration of infectivity meant the infection process started at a higher level, causing the animals to reach a symptomatic stage of disease before their life’s end.
The research resulted in two findings, one being the ability of synthetic wild-type prion protein to induce prion disease in normal wild-type hosts and the other being the development of a new strain of hamster prion disease with a unique presentation for rodents that may prove valuable for investigating the longer duration TSE illnesses of larger animals like humans and cattle.
The VA Maryland Health Care System (VAMHCS) provides a broad spectrum of medical, surgical, rehabilitative, mental health and outpatient care to veterans at two medical centers, one community living & rehabilitation center and five outpatient clinics located throughout the state. More than 52,000 veterans from various generations receive care from the VAHMCS annually. Nationally recognized for its state-of-the-art technology and quality patient care, the VAHMCS is proud of its reputation as a leader in veterans’ health care, research and education. It costs nothing for Veterans to enroll for health care with the VA Maryland Health Care System and it could be one of the more important things a Veteran can do. For information about VA health care eligibility and enrollment or how to apply for a VA medical care hardship to avoid future copayments for VA health care, interested Veterans are urged to call the Enrollment Center for the VA Maryland Health Care System, Monday through Friday, from 8 a.m. to 4:30 p.m. at 1-800-463-6295, ext. 7324 or visit www.maryland.va.gov
Rosalia Scalia | Newswise Science News
Zebrafish's near 360 degree UV-vision knocks stripes off Google Street View
22.06.2018 | University of Sussex
New cellular pathway helps explain how inflammation leads to artery disease
22.06.2018 | Cedars-Sinai Medical Center
In a recent publication in the renowned journal Optica, scientists of Leibniz-Institute of Photonic Technology (Leibniz IPHT) in Jena showed that they can accurately control the optical properties of liquid-core fiber lasers and therefore their spectral band width by temperature and pressure tuning.
Already last year, the researchers provided experimental proof of a new dynamic of hybrid solitons– temporally and spectrally stationary light waves resulting...
Scientists from the University of Freiburg and the University of Basel identified a master regulator for bone regeneration. Prasad Shastri, Professor of...
Moving into its fourth decade, AchemAsia is setting out for new horizons: The International Expo and Innovation Forum for Sustainable Chemical Production will take place from 21-23 May 2019 in Shanghai, China. With an updated event profile, the eleventh edition focusses on topics that are especially relevant for the Chinese process industry, putting a strong emphasis on sustainability and innovation.
Founded in 1989 as a spin-off of ACHEMA to cater to the needs of China’s then developing industry, AchemAsia has since grown into a platform where the latest...
The BMBF-funded OWICELLS project was successfully completed with a final presentation at the BMW plant in Munich. The presentation demonstrated a Li-Fi communication with a mobile robot, while the robot carried out usual production processes (welding, moving and testing parts) in a 5x5m² production cell. The robust, optical wireless transmission is based on spatial diversity; in other words, data is sent and received simultaneously by several LEDs and several photodiodes. The system can transmit data at more than 100 Mbit/s and five milliseconds latency.
Modern production technologies in the automobile industry must become more flexible in order to fulfil individual customer requirements.
An international team of scientists has discovered a new way to transfer image information through multimodal fibers with almost no distortion - even if the fiber is bent. The results of the study, to which scientist from the Leibniz-Institute of Photonic Technology Jena (Leibniz IPHT) contributed, were published on 6thJune in the highly-cited journal Physical Review Letters.
Endoscopes allow doctors to see into a patient’s body like through a keyhole. Typically, the images are transmitted via a bundle of several hundreds of optical...
13.06.2018 | Event News
08.06.2018 | Event News
05.06.2018 | Event News
22.06.2018 | Materials Sciences
22.06.2018 | Earth Sciences
22.06.2018 | Life Sciences